Box Layout

HTML Layout
Backgroud Images
Backgroud Pattern
  • E-mail : info_medicalmarketing@jindunmedical.com
  • Phone : +86 21 64057580
  • Address : Shanghai China

Prasugrel, although good, is a difficult substitute for clopidogrel in elderly patients with coronary artery disease

  • 2022-10-09
  • JINDUN MEDICAL

5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]- 5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2 (4h)-one is used as the intermediate of Prasugrel .

بیشتر بخوانید

Reducing GI damage and replacing aspirin with clopidogrel, what to look for

  • 2022-10-09
  • JINDUN MEDICAL

D-(+)-Methyl-alpha-(2-thienylethamino)(2-chlorophenyl)acetate hydrochloride is used as the intermediate of Clopidogrel .

بیشتر بخوانید

Newly approved diabetes treatment drugs on the market, no miracle drugs, beware of deception, you need to know

  • 2022-10-09
  • JINDUN MEDICAL

2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile is used as the intermediate of Trelagliptin succinate .

بیشتر بخوانید

Sodium 8 - (2-hydroxybenzamido) octanoate Salcaprozate Sodium Manufacturer

  • 2022-10-09
  • JINDUN MEDICAL

Sodium 8 - (2-hydroxybenzamido) octanoate, or SNAC for short, is a kind of absorption promoter of dicarbophosphate compounds, which is used to treat gastrointestinal diseases, espe

بیشتر بخوانید

2,6-Dichlorobenzaldehyde,CAS NO.83-38-5,export,manufacture ,supplier

  • 2022-10-09
  • JINDUN MEDICAL

2,6-dichlorobenzaldehyde is an important intermediate in the synthesis of benzoylurea insecticides. It is used to synthesize the next intermediate, 2,6-dichlorobenzaldehyde oxime,

بیشتر بخوانید

Dimethyl sulfoxide industry in China after 2021 driven by the dual factors of export and domestic demand rapid development

  • 2022-10-09
  • JINDUN MEDICAL

It can be used as organic solvent, reaction medium and organic synthesis intermediate.

بیشتر بخوانید

How far can anti-TB treatment with linezolid really go?

  • 2022-10-09
  • JINDUN MEDICAL

Linezolid is a new synthetic antibacterial drug of oxazolidinone developed and produced by Pharmacia&Upiohn Company (acquired by Pfizer) in the United States.

بیشتر بخوانید

Latest data on ibrutinib in combination with venetoclax for first-line treatment of chronic lymphocytic leukemia released

  • 2022-10-09
  • JINDUN MEDICAL

On June 10, 2021, the American Journal of Medicine published a non-randomized phase II trial to evaluate the efficacy and safety of ibrutinib in combination with venetoclax in the

بیشتر بخوانید

Clinical data and adverse effects of venetoclax combined with azacitidine in the treatment of myelodysplastic syndrome

  • 2022-10-09
  • JINDUN MEDICAL

Used to synthesize BTK, PI3K and JAK-2 inhibitors, as well as pharmaceutical intermediates.

بیشتر بخوانید